OSE Immunotherapeutics (STU:6OP) FFO


STU:6OP OSE Immunotherapeutics SA STU:6OP
43 GF Score
Price €3.31
GF Value €1.45
Valuation Significantly Overvalued
! 6 Warning Signs
View Full Analysis

What is OSE Immunotherapeutics FFO?

FFO (Funds from operations) only applies to REITs.

STU:6OP
43GF Score
OSE Immunotherapeutics SA STU:6OP
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is OSE Immunotherapeutics (STU:6OP) Overvalued in 2026?

Based on GuruFocus' analysis, OSE Immunotherapeutics stock appears to be overvalued. The current stock price of €3.31 is trading 128.3% above its estimated GF Value™ of €1.45. GuruFocus considers OSE Immunotherapeutics to be Significantly Overvalued.

Key valuation signals for STU:6OP:

  • FFO:
  • GF Value™: €1.45 vs. price of €3.31 (128.3% above fair value)
  • GF Score™: 43/100 with 6 warning signs

No single metric tells the full story. See the STU:6OP stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


OSE Immunotherapeutics Business Description

Other Exchanges ORPOF:USA0RAD:UKOSE:France
Address 22, Boulevard Benoni Goullin, Nantes, FRA, 44200
OSE Immunotherapeutics SA is a France-based biotechnology company focused on the development of immunotherapies for immune activation and regulation in the fields of immuno-oncology and autoimmune diseases. The product portfolio of the company comprises Tedopi, OSE-172, OSE-703, FR104 and OSE-127.
43GF Score

Get the complete analysis for STU:6OP

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€3.31
Price
€1.45
GF Value